Antitumor activity of an adenovirus harboring two therapeutic genes, anti-VEGF ribozyme and human IL-24, in colon cancer

Chen
2009 Molecular Medicine Reports  
increased vascular endothelial growth factor (VeGF) expression and tumor vascularization are correlated with both tumor progression and a poor clinical prognosis in colon cancer. There is increasing evidence that mda-7/il-24 has potent growth suppression activity and induces apoptosis in many different tumor cells. We constructed a recombinant replication-deficient adenovirus carrying both an anti-VEGF hairpin ribozyme and human il-24 (ad-rz/il-24) with an internal ribosome entry site and
more » ... its VeGF inhibition effect and antitumor activity. The results showed that ad-rz/ IL-24 significantly inhibited VEGF expression and angiogenesis in vitro and in vivo. The proliferation rate of xenograft tumors treated with ad-rz/il-24 was approximately 50% lower than the rate of the xenograft tumors treated with adenovirus carrying a single gene anti-VeGF hairpin ribozyme (ad-rz) or IL-24 (Ad-IL-24) alone. These findings demonstrated the potential therapeutic effect of this dual gene-expressing adenovirus for cancer gene therapy.
doi:10.3892/mmr_00000158 pmid:21475887 fatcat:btt7yexoffbbrdwee5377njg2e